AL
Last reporting period 31 Mar, 2024
Updated —
Last price
—
Market cap $B
4.457
Exchange
XNAS - Nasdaq
0.33 B
Last period Equity ,USD
488%
Equity has increased in 5 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also Alpine Immune
Company Analysis
ALPN valuation, rating, competitors, insights and company profile
Eyestock Rating
ALPN financial analysis by Eyestock methodology
Valuation
ALPN valuation using historical relative method
Statements
ALPN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ALPN dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
Alpine Immune`s Equity for the period ended 2024-03-31 is 0.33 B USD
